The 0.5 mg Elora Nobody Wants to Claim

QH says it only promoted it, APKX says its version passed “internal testing,” and the supplier behind the 0.5 mg result remains a mystery.

Krysia

The controversial COA that kicked things off

This whole debacle started when I was shown a COA for Elora 5 showing just 0.5 mg instead of the labelled 5 mg.

I posted the COA alongside kit pictures which turned out to be the wrong kit pictures. Someone recognised that the COA had previously been posted in cropped form by another account, and shortly after the vendor who originally shared it with me asked me to remove the COA which I did.

I was then sent a photograph of what I was told is the underdosed Elora kit by someone who told me the original poster had sent it to him in response to his tweet.

The box is labelled “Elor 5,” claiming 5 mg per vial and carrying the code CP01260704475L. He also forwarded a screenshot from QH’s Telegram group which shows a QH representative named Tina posting what looks to be the same kit, carrying the same name, dosage and code.

Underneath the picture, Tina had asked:

“Is there anyone who needs this peptide?”

Based on that screenshot, I posted that QH Tina is selling the product.

QH Demands the Post Is Removed

A woman named Vicky then contacted me and identified herself as a member of QH’s official sales team. She said QH had never sold the product, accused the person who sent the information of lying and repeatedly asked for his contact details. She also asked me to write an article clarifying that the kit was “definitely not” a QH product.

Vicky said the allegation had seriously damaged QH’s reputation and demanded that I delete the post. However, the picture had come directly from QH’s own Telegram group and had been posted by its own representative.

When I showed Vicky the original group post, she changed her argument. She was no longer denying that Tina had promoted the kit. Instead, she wanted evidence that somebody had actually purchased it from her. She requested proof of payment, packing photographs and a shipping number. She said that without this evidence, the person who supplied the screenshots should apologise.

But nobody was actually claiming to have purchased the kit from Tina. The screenshots were sent to show that QH had been offering what appeared to be the same Elora product.

From “Not Our Product” to “Our Product”

However, in her final message, Vicky wrote:

“He cannot merely rely on this one picture and then claim that there is something wrong with our product.”

It still doesn’t prove that QH supplied the vial that tested at 0.5 mg, but QH can’t simultaneously insist that the product was never theirs and then defend it as “our product.”

Tina Says She Promoted It but Never Sold It

Tina also contacted me directly. She explained that the product was expensive and customers couldn’t order it in sufficiently large quantities, so nobody ultimately placed an order with her. Tina also claimed that someone had taken her “designs” and used them to sell incorrect products. After I showed her the picture of her asking if anyone needs this peptide, she admitted that it was the promotional picture she published not the outbound picture and told me;

“I didn’t sell a box at all, I just asked who needed it.”

She also said that its not her inventory and that the company has never sold that product. She said the kits sold by other people were not necessarily hers. So if it wasn’t QH inventory and hadn’t been ordered, where did the physical promotional kit come from, and who produced it?

QH has not explained that.

Screenshots and Invites Disabled

The person who originally saw Tina’s post later returned to QH’s Telegram group to collect the evidence. By then, the ability to forward or save content from the group had been disabled, so he had to use another phone to photograph and record the original post. He also found that invitation links had been disabled, preventing new members from joining through the link.

The timing is notable because these restrictions appear to have been introduced on the same day QH began demanding that the post be removed and denying that Tina had offered the product.

Then Another Supplier Appeared

While QH was distancing itself from the product, another supplier was found openly advertising Elora 5 kits in extremely similar packaging.

APKX posted a dissolution video for what it described as its “new Elor5 product.” The company said it had successfully passed internal testing and was available to order.

A representative then advertised the latest shipment for $229 per box, with further discounts for bulk purchases.

However, APKX didn’t publish an independent COA. The evidence shown was a video of the product dissolving.

The code visible on the APKX packaging also appears to differ from the code on the reported underdosed kit, so there is currently no evidence that the two came from the same batch. What is clear is that the packaging is extremely similar.

What Can Actually Be Established?

There is currently no evidence proving that either QH or APKX supplied the vial connected to the 0.5 mg result. There’s also no justification for claiming that QH sold that particular kit simply because Tina promoted something that looked the same.

But QH cannot reasonably deny all involvement with the product when its own representative photographed it, posted it in the company group and asked customers who wanted it.

That’s where this story currently stands: one severely underdosed result, suppliers promoting almost identical Elora kits and no confirmed source for the tested vial.

Everybody appears happy to advertise Elora when orders are available, but once a vial tests at a tenth of its labelled amount, nobody wants to claim it

Comments